March 25, 2024

68Ga-DOTA-IBA Uptake in Breast cancer

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Abstract A 77-year-old woman with recently diagnosed breast cancer underwent 68 Ga-labeled DOTA-ibandronic acid ( 68 Ga-DOTA-IBA) PET/CT scan for the evaluation of bone metastases. The examination revealed increased tracer uptake, indicating that the cervical vertebrae presented osteoblastic metastasis. Interestingly, the breast cancer also showed enhanced activity of 68 Ga-DOTA-IBA.

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Xiang et al. (Mon,) studied this question.

synapsesocial.com/papers/68e72644b6db6435876a046a https://doi.org/https://doi.org/10.1097/rlu.0000000000005200

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Rare Thyroid Cartilage Metastasis From Breast Cancer Visualized on 18F-NaF PET/CT2020 · 8 citations
2Lutetium177-Labeled DOTA-Ibandronate: A Novel Radiopharmaceutical for Targeted Treatment of Bone Metastases2023 · 45 citations
3Incremental Value of Cocktail 18F-FDG and 18F-NaF PET/CT Over 18F-FDG PET/CT Alone for Characterization of Skeletal Metastases in Breast Cancer2017 · 18 citations
4The Detection of Uterine Leiomyoma (Fibroid) Calcifications on 18F-NaF PET/CT2018 · 16 citations
5Preparation, biological characterization and preliminary human imaging studies of 68Ga-DOTA-IBA2022 · 39 citations

Preguntar a la IA

Me gusta

Guardar